Type of Deal: Acquisition by wholly-owned subsidiary IKS Inc.
Funding Source: Debt financing through multiple international lenders
Financing Structure:
Facilities agreement dated July 3, 2026 executed with multiple parties
Lenders include: Citibank, N.A.; Deutsche Bank AG, Singapore Branch; Export-Import Bank of India, London Branch; JPMorgan Chase Bank, N.A., Hong Kong Branch
Arrangers include: Citigroup Global Markets Asia Limited; Deutsche Bank AG, Singapore Branch; JPMorgan Chase Bank, N.A., Hong Kong Branch
Axis Trustee Services Ltd., GIFT City Branch serves as Agent and Security Agent
Security Arrangements:
Pledge and security agreement dated July 3, 2026 executed by Company with Security Agent
Power of attorney dated July 3, 2026 executed by Company to appoint Security Agent
Letter of comfort dated July 3, 2026 issued by Company to Agent
Security created to secure the Facilities for the acquisition
Company Commitments:
Company will continue to exercise effective oversight on IKS Inc.'s governance practices
Company will oversee capital management strategies and investment strategies of IKS Inc.
Previous Communications: Referenced earlier communications dated April 23, 2026 and July 2, 2026
Additional Information: Available on company website at https://ikshealth.com/investor-relations/
